NYSE · Healthcare · Healthcare Plans

Elevance Health, Inc. (ELV)

As of Sep 25, 4:00 PM ET, Elevance Health (ELV) last traded at $396.09, down 0.54% on the day. Its TickerHum research score is 57/100 (average). It reported revenue of $201.11B for the twelve months ending 2026-06-30, up 6.3% year over year, with a 2.7% operating margin.

Ratings

Reported fundamentals

MetricValuePeriod
Revenue$201.11BTTM ending 2026-06-30 · 10-Q
Revenue growth6.3%TTM ending 2026-06-30 · 10-Q
Net income$4.96BTTM ending 2026-06-30 · 10-Q
Diluted EPS$22.61TTM ending 2026-06-30 · 10-Q
Operating margin2.7%TTM ending 2026-06-30 · 10-Q
Net margin2.5%TTM ending 2026-06-30 · 10-Q
Free cash flow$6.29BTTM ending 2026-06-30 · 10-Q
Cash$10.23Bas of 2026-06-30 · 10-Q
Long-term debt$30.67Bas of 2026-06-30 · 10-Q
Debt / equity0.68as of 2026-06-30 · 10-Q

Source: SEC EDGAR XBRL company facts (CIK 0001156039).

Compare Elevance Health with its closest competitors

Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.